EVR Research’s ICU Medical ICUI Stock Holding History

EVR Research’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,000	Closed	-$4.53M	–	32
2021 Q2	$4.53M	Hold	22,000	–	–	2.63%	19
2021 Q1	$4.52M	Hold	22,000	–	–	3.44%	12
2020 Q4	$4.72M	Buy	+22,000	New	+$4.27M	3.86%	10

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EVR Research's ICUI Position: Q3 2021 in Review

EVR Research sold out of ICU Medical (ICUI) in Q3 2021, closing a stake of 22,000 shares — an estimated $4.53M sold.

EVR Research first reported a position in ICUI in Q4 2020 and held it in 3 quarters. The position peaked at $4.72M in Q4 2020. 276 funds tracked by Wall St. Rank hold ICUI as of Q3 2021.

EVR Research reported no remaining ICU Medical position as of Q3 2021 after selling out during the quarter.
EVR Research sold 22,000 ICU Medical shares in Q3 2021, an estimated $4.53M.
EVR Research first reported a position in ICU Medical in Q4 2020 and held it in 3 quarters.
EVR Research's ICU Medical position peaked at $4.72M in Q4 2020.
276 funds tracked by Wall St. Rank held ICU Medical as of Q3 2021.

Based on EVR Research's 13F filing for Q3 2021, filed 15 Nov 2021.